These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37936627)

  • 1. Long-Term Assessment of Thin-Strut BioMime Coronary Stent System in Real-World Population at Single-Center: A Retrospective Observational Study.
    Meennahalli Palleda G; Gupta M; Bansal A; Batra V; Tyagi S; Kunal S
    Cardiol Res; 2023 Oct; 14(5):360-369. PubMed ID: 37936627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized Controlled Trial Comparing BioMime Sirolimus-Eluting Stent With Everolimus-Eluting Stent: Two-Year Outcomes of the meriT-V Trial.
    Abizaid A; Costa R; Kedev S; Kedhi E; Talwar S; Erglis A; Hlinomaz O; Masotti M; Fath-Ordoubadi F; Milewski K; Lemos P; Botelho R; Ijsselmuiden A; Koolen J; Kala P; Janssens L; Chandra U
    Cardiol Res; 2023 Aug; 14(4):291-301. PubMed ID: 37559713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
    Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Outcomes of World's Thinnest (50 μmr) Strut Biodegradable Polymer Coated Everolimus-Eluting Coronary Stent System in Real-World Patients.
    Patted SV; Patted AS; Turiya PK; Thakkar AS
    Cardiol Res; 2018 Dec; 9(6):370-377. PubMed ID: 30627288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel completed biodegradable polymer sirolimus-eluting stent versus durable polymer sirolimus-eluting stent in de novo lesions: nine-month angiographic and three-year clinical outcomes of HOPE trial.
    Yuan F; Chen X; Song X; Wang D; Zhang Z; Li W; Li Z; Li H; Chen X; Huo Y; Wang L; Lu C; Lu Q; Xu B; Li W; Lyu S;
    Chin Med J (Engl); 2014; 127(14):2561-6. PubMed ID: 25043067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thin Strut CoCr Biodegradable Polymer Biolimus A9-Eluting Stents versus Thicker Strut Stainless Steel Biodegradable Polymer Biolimus A9-Eluting Stents: Two-Year Clinical Outcomes.
    Menown IBA; Mamas MA; Cotton JM; Hildick-Smith D; Eberli FR; Leibundgut G; Tresukosol D; Macaya C; Copt S; Slama SS; Oldroyd KG
    J Interv Cardiol; 2021; 2021():6654515. PubMed ID: 33880087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients.
    Roguin A; Kandzari DE; Marcusohn E; Koolen JJ; Doros G; Massaro JM; Garcia-Garcia HM; Bennett J; Gharib EG; Cutlip DE; Waksman R
    Circ Cardiovasc Interv; 2018 Oct; 11(10):e007331. PubMed ID: 30354631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Clinical Performance of Biodegradable Polymer-Coated Ultra-Thin Everolimus-Eluting Stents in "Real-World" Patients: A Multicenter Registry (PERFORM-EVER).
    Kasturi S; Polasa S; Sowdagar MA; Kumar P; Reddy T; Nichenamatla C; Singh S; Reddy V
    Anatol J Cardiol; 2022 Aug; 26(8):619-628. PubMed ID: 35924288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial.
    von Birgelen C; Kok MM; van der Heijden LC; Danse PW; Schotborgh CE; Scholte M; Gin RMTJ; Somi S; van Houwelingen KG; Stoel MG; de Man FHAF; Louwerenburg JHW; Hartmann M; Zocca P; Linssen GCM; van der Palen J; Doggen CJM; Löwik MM
    Lancet; 2016 Nov; 388(10060):2607-2617. PubMed ID: 27806902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial.
    Iglesias JF; Muller O; Heg D; Roffi M; Kurz DJ; Moarof I; Weilenmann D; Kaiser C; Tapponnier M; Stortecky S; Losdat S; Eeckhout E; Valgimigli M; Odutayo A; Zwahlen M; Jüni P; Windecker S; Pilgrim T
    Lancet; 2019 Oct; 394(10205):1243-1253. PubMed ID: 31488372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seven-year clinical outcomes in patients undergoing percutaneous coronary intervention with biodegradable polymer coated sirolimus-eluting stent: Results from a single-center real-world experience.
    Abhyankar A; Kaul U; Sinha SK
    Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S280-S284. PubMed ID: 30595275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents: 3-Year Outcomes of BIO-RESORT.
    Buiten RA; Ploumen EH; Zocca P; Doggen CJM; Danse PW; Schotborgh CE; Scholte M; van Houwelingen KG; Stoel MG; Hartmann M; Tjon Joe Gin RM; Somi S; Linssen GCM; Kok MM; von Birgelen C
    JACC Cardiovasc Interv; 2019 Sep; 12(17):1650-1660. PubMed ID: 31422087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of Thin-Strut Stents in Non-Left Main Bifurcation Coronary Lesions: A RAIN Subanalysis.
    De Filippo O; D'Ascenzo F; Angelini F; Franchin L; Cerrato E; Pennacchi M; Nuñez-Gil I; Wojakowski W; Imori Y; Trabattoni D; Huczek Z; Venuti G; Muscoli S; Iannaccone M; Montabone A; Marengo G; Rognoni A; Parma R; Figini F; Mitomo S; Boccuzzi G; Mattesini A; Quadri G; Wańha W; Smolka G; Rolfo C; Cortese B; Ryan N; Capodanno D; Chieffo A; di Mario C; Varbella F; Romeo F; Sheiban I; Escaned J; Helft G; De Ferrari GM
    J Invasive Cardiol; 2021 Nov; 33(11):E890-E899. PubMed ID: 34735352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nine-Months Clinical Outcome of Biodegradable Polymer Coated Sirolimus-eluting Stent System: A Multi-Centre "Real-World" Experience.
    Sarma R; Prajapati J; Raheem A; Thakkar K; Kothari S; Thakkar A
    J Clin Diagn Res; 2015 Aug; 9(8):OC23-6. PubMed ID: 26435986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions).
    Gada H; Kirtane AJ; Newman W; Sanz M; Hermiller JB; Mahaffey KW; Cutlip DE; Sudhir K; Hou L; Koo K; Stone GW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1263-6. PubMed ID: 24239202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-Year Outcomes of Biodegradable Polymer-Coated Ultra-Thin (60 µm) Sirolimus-Eluting Stents in Real-World Clinical Practice.
    Chandwani P; Meel B; Singhal R; Jangid K; Ahmed R; Yadav M; Gupta AK; Chopra R
    Ann Acad Med Singap; 2019 May; 48(5):150-155. PubMed ID: 31210252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent for the treatment of de novo coronary lesions: 5-year results of the TARGET Ⅱ trial].
    Xu LJ; Gao Z; Song Y; Wang HH; Xu JJ; Gao LJ; Zhang Y; Song L; Zhao XY; Chen J; Yuan JQ; Qiao SB; Yang YJ; Xu B; Gao RL;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Jul; 46(7):523-528. PubMed ID: 30032542
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized Trial.
    Iglesias JF; Heg D; Roffi M; Tüller D; Noble S; Muller O; Moarof I; Cook S; Weilenmann D; Kaiser C; Cuculi F; Häner J; Jüni P; Windecker S; Pilgrim T
    Circ Cardiovasc Interv; 2019 Aug; 12(8):e008024. PubMed ID: 31525083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year outcomes of a BioMime™ Sirolimus-Eluting Coronary Stent System with a biodegradable polymer in all-comers coronary artery disease patients: The meriT-3 study.
    Jain RK; Chakravarthi P; Shetty R; Ramchandra P; Polavarapu RS; Wander GS; Mohan B; Banker DN; Dharmadhikari A; Bansal SS; Jain N; Solanki D; Dhakaan J; Sharma VP; Mohanan PP; Ashokan PK; Manjunath BV; Hiregoudar N; Patil C; Balakrishnan N
    Indian Heart J; 2016; 68(5):599-603. PubMed ID: 27773396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.